Martinsried, Germany – KINAXO Biotechnologies GmbH announced today that it has entered into a collaboration with AstraZeneca. Under the terms of the agreement, KINAXO will

Goettingen, Germany – Effective January 1, 2011, the former Millipore executive, Dominique Baly, has assumed cross-divisional management of marketing,

Biogen Idec (NASDAQ: BIIB) and Neurimmune Holding AG today announced that Biogen Idec has acquired a subsidiary of Neurimmune, which includes the world-wide rights to

Effective September 28th, 2010, Hamburg based HELM AG has purchased a 30% shareholding in Amarin Technologies S.A. a privately owned pharmaceutical development

Gene Logic, an Ocimum Biosolutions company, a leading provider of genomic solutions, is pleased to

Dutch vaccine development company Mucosis B.V. announced today that it has received an innovation

VaxGen, Inc. , a biopharmaceutical company, and diaDexus, Inc., a privately held diagnostics company

Life Technologies Corporation, a provider of innovative life science solutions, announced today that it has

April 23, 2010 – “So far, companies including Johnson & Johnson, Eli Lilly, Abbott, Amgen and Gilead have

April 22, 2010 – According to a new technical market research report, Biological Therapies for Cancer: